Stock comparison
Harmony Biosciences Holdings
BeOne Medicines
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HRMY
Harmony Biosciences Holdings
Market cap
$1.75B
Sector
Healthcare
ONC
BeOne Medicines
Market cap
$33.15B
Sector
Healthcare
Overall winner
BeOne Medicines ONC
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | HRMY | ONC | Winner |
|---|---|---|---|
| Warren Buffett | 67B | 62D | HRMY |
| Benjamin Graham | 60C | 75D | ONC |
| Philip Fisher |
Side-by-side metrics
| Metric | HRMY | ONC |
|---|---|---|
| Market cap | $1.75B | $33.15B |
| P/E (TTM) | 11.8x | 107.5x |
| EV/EBIT | 6.4x | 28.9x |
| ROIC (TTM) | 12.5% | 7.73% |
| Gross margin | 76.55% | 87.17% |
| Net margin | 16.2% | 8.93% |
| Revenue CAGR 5y | 29.85% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HRMY leads on
- P/E (TTM)11.8xvs 107.5x+89%
- EV/EBIT6.4xvs 28.9x+78%
- Debt / Equity0.2xvs 0.4x+47%
- Net margin16.2%vs 8.93%
More like ONC
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.